US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 1.8400
  • -0.0050-0.27%
Close Dec 20 16:00 ET
  • 1.8487
  • +0.0087+0.47%
Post 19:59 ET
66.42MMarket Cap-0.42P/E (TTM)

About Inovio Pharmaceuticals Company

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Company Profile

SymbolINO
Company NameInovio Pharmaceuticals
Listing DateDec 8, 1998
Founded1983
CEODr. Jacqueline E. Shea
MarketNASDAQ
Employees122
Fiscal Year Ends12-31
Address660 West Germantown Pike,Suite 110
CityPlymouth Meeting
ProvincePennsylvania
CountryUnited States of America
Zip Code19462-1111
Phone1-267-440-4200

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jacqueline E. Shea
  • President, Chief Executive Officer and Director
  • 2.07M
  • Michael John Sumner
  • Chief Medical Officer
  • --
  • Dr. Laurent Humeau, PhD
  • Chief Scientific Officer
  • 976.66K
  • Peter D. Kies
  • Chief Financial Officer and Principal Accounting Officer
  • 988.73K
  • Simon X. Benito
  • Chairman of the Board
  • 151.19K
  • Dr. David B. Weiner, PhD
  • Director
  • 201.79K
  • Wendy L. Yarno, M.B.A.
  • Independent Director
  • 123.69K
  • Jay P. Shepard
  • Independent Director
  • 119.31K
  • Dr. Roger D. Dansey, M.D.
  • Independent Director
  • 108.69K
  • Lota S. Zoth, C.P.A.
  • Independent Director
  • 118.69K
  • Dr. Ann C. Miller, M.D.
  • Independent Director
  • 126.94K
Heat List
US
Overall
Symbol
Price
% Chg

No Data